LORI SAUNDERS: Open Payments
NPI 1215991088 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 64 payments from 12 companies in 2025. Trend: 2023 $1,543 · 2024 $1,266 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $290 |
| QOL Medical, LLC | 13 | $161 |
| Janssen Biotech, Inc. | 7 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $74 |
| Intercept Pharmaceuticals, Inc. | 3 | $62 |
| VIVUS LLC | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 4 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
Products named: Sucraid, RINVOQ, TREMFYA, Linzess, OCALIVA, QSYMIA, VOQUEZNA, XIFAXAN.
Industry payments across CA — which companies pay providers there.
